High myopia, pathological myopia and suffering in the vitreous, retinal increasing qualitative changes and after cataract surgery within three months should exercise caution regarding the patient.

• 高度近视、病理性近视及患有玻璃体、视网膜增质性改变和白内障术后三个月以内的患者应慎用。